Lacticaseibacillus rhamnosus HN001 enhances intestinal barrier function and protects the blood-brain barrier from inflammatory disruption in vitro
Frontiers in Physiology · 08.05.2026 · 17
DOI: 10.3389/fphys.2026.1808663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 08.05.2026. Verfasst von Dulantha Ulluwishewa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bioeconomy Science Institute, Te Rourou, Palmerston North, New Zealand. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Business, Innovation and Employment.
Abstract (Originalsprache)
The integrity of the intestinal epithelial and blood-brain barriers is critical for maintaining homeostasis along the gut-brain axis as these interfaces regulate the passage of inflammatory mediators into systemic circulation and their access to the brain. Disruption of these barriers can lead to neuroinflammatory processes implicated in mood disturbances. Lacticaseibacillus rhamnosus HN001 has been associated with improved mood outcomes in clinical and preclinical studies, however the mechanistic basis for these effects is unclear. Here, we investigated whether HN001 enhances intestinal and blood-brain barrier function in a two-stage in vitro gut-brain axis model. Differentiated Caco-2 epithelial monolayers were co-cultured with HN001 (Stage-1; intestinal epithelial barrier), and the conditioned basal medium from this stage was subsequently applied to hCMEC/D3 endothelial monolayers (Stage-2; blood-brain barrier). HN001 increased transepithelial electrical resistance in Caco-2 monolayers under both aerobic and apical-anaerobic conditions. This was accompanied by transcriptional modulation of tight-junction signaling, including upregulation of OCLN and sealing claudins, and downregulation of the pore-forming claudin CLDN2 . Conditioned basal medium collected from HN001-treated Caco-2 intestinal epithelial monolayers improved barrier resistance in hCMEC/D3 brain endothelial monolayers and mitigated IL-1β-induced barrier disruption. The protective effect was not accompanied by changes in IL-1β-stimulated secretion of IL-6, IL-8, MCP-1, TNF-α or IL-1β, indicating that HN001-derived signals regulate blood-brain barrier function independently of the cytokines measured here. Together, these findings indicate that HN001 supports both the intestinal barrier and the blood-brain barrier integrity within the gut-brain axis. By regulating these barrier interfaces, HN001 may reduce susceptibility to neuroinflammation, suggesting a potential mechanistic basis for its previously reported psychobiotic benefits.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bioeconomy Science Institute, Te Rourou, Palmerston North, New Zealand.
- School of Medical Sciences, The University of Auckland, Auckland, New Zealand.
Förderung
- Ministry of Business, Innovation and Employment
Zitieren
APA
Ulluwishewa, D., Purba, A., Fegan, V., Na, N., O'Carroll, S. J., & Anderson, R. C. (2026). Lacticaseibacillus rhamnosus HN001 enhances intestinal barrier function and protects the blood-brain barrier from inflammatory disruption in vitro. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.1808663
Vancouver
Ulluwishewa D, Purba A, Fegan V, Na N, O'Carroll SJ, Anderson RC. Lacticaseibacillus rhamnosus HN001 enhances intestinal barrier function and protects the blood-brain barrier from inflammatory disruption in vitro. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.1808663
BibTeX
@article{Ulluwishewa2026,
author = {Ulluwishewa, Dulantha and Purba, Ajitpal and Fegan, Vincent and Na, Narsaa and O'Carroll, Simon J and Anderson, Rachel C},
title = {Lacticaseibacillus rhamnosus HN001 enhances intestinal barrier function and protects the blood-brain barrier from inflammatory disruption in vitro},
journal = {Frontiers in Physiology},
year = {2026},
volume = {17},
doi = {10.3389/fphys.2026.1808663}
}
EUVIMED